Chinese Association of Idaho State University (CAISU)
Raw Orlistat powder is a therapeutic drug for obesity that does not act on the central nervous system. It acts only on the gastrointestinal tract, inhibits the hydrolysis of triglyceride into free fatty acids and monoacylglycerides by inhibiting the lipase of the gastrointestinal tract, and reduces the absorption of fat (triacylglycerol) in the diet by the intestinal mucosa, and promotes the elimination of fat in vitro. Lipase is an enzyme necessary for the gastrointestinal tract to break down fat. This product can bind to the serine residue of stomach and pancreatic lipase, and inactivate lipase, so that it can not break down fat in food into free fatty acid and inhibit fat. Utilization and absorption, in addition, this product can reduce the risk factors associated with obesity.
Obesity and overweight who have undergone moderate dietary control and exercise, including long-term treatment of patients who have already developed obesity-related risk factors (diabetes, hypertension, dyslipidemia, etc.).